Your browser doesn't support javascript.
loading
Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson's Disease.
Tsitsi, Panagiota; Benfatto, Mattias Nilsson; Seimyr, Gustaf Öqvist; Larsson, Olof; Svenningsson, Per; Markaki, Ioanna.
Afiliação
  • Tsitsi P; Department of Clinical Neuroscience, Neuro, Karolinska Institutet, Stockholm, Sweden.
  • Benfatto MN; Center of Neurology, Academic Specialist Center, Region Stockholm, Sweden.
  • Seimyr GÖ; Department of Clinical Neuroscience, Eye and Vision, Karolinska Institutet, Stockholm, Sweden.
  • Larsson O; Department of Clinical Neuroscience, Eye and Vision, Karolinska Institutet, Stockholm, Sweden.
  • Svenningsson P; Department of Clinical Neuroscience, Eye and Vision, Karolinska Institutet, Stockholm, Sweden.
  • Markaki I; Department of Clinical Neuroscience, Neuro, Karolinska Institutet, Stockholm, Sweden.
J Parkinsons Dis ; 11(2): 865-875, 2021.
Article em En | MEDLINE | ID: mdl-33612496
ABSTRACT

BACKGROUND:

Visual and oculomotor problems are very common in Parkinson's disease (PD) and by using eye-tracking such problems could be characterized in more detail. However, eye-tracking is not part of the routine clinical investigation of parkinsonism.

OBJECTIVE:

To evaluate gaze stability and pupil size in stable light conditions, as well as eye movements during sustained fixation in a population of PD patients and healthy controls (HC).

METHODS:

In total, 50 PD patients (66% males) with unilateral to mild-to-moderate disease (Hoehn & Yahr 1-3, Schwab and England 70-90%) and 43 HC (37% males) were included in the study. Eye movements were recorded with Tobii Pro Spectrum, a screen-based eye tracker with a sampling rate of 1200 Hz. Logistic regression analysis was applied to investigate the strength of association of eye-movement measures with diagnosis.

RESULTS:

Median pupil size (OR 0.811; 95% CI 0.666-0.987; p = 0.037) and longest fixation period (OR 0.798; 95% CI 0.691-0.921; p = 0.002), were the eye-movement parameters that were independently associated with diagnosis, after adjustment for sex (OR 4.35; 95% CI 1.516-12.483; p = 0.006) and visuospatial/executive score in Montreal Cognitive Assessment (OR 0.422; 95% CI 0.233-0.764; p = 0.004). The area under the ROC curve was determined to 0.817; 95% (CI) 0.732-0.901.

CONCLUSION:

Eye-tracking based measurements of gaze fixation and pupil reaction may be useful biomarkers of PD diagnosis. However, larger studies of eye-tracking parameters integrated into the screening of patients with suspected PD are necessary, to further investigate and confirm their diagnostic value.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Parkinsons Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Parkinsons Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia